Actimab-A
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Actimab-A, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma [Phase 1]